BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that it will host a webcast and teleconference with senior management to discuss its financial results and operating highlights for the fourth quarter and full year ended December 31, 2011 on Tuesday, March 13, 2012, at 5:00 pm Eastern. These results are expected to be released after the capital markets close that day.
Investors interested in accessing the live audio webcast of the teleconference may do so at http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-calendar and should log on 10 to 15 minutes before the teleconference begins in order to download any software required. A replay of the webcast will also be available on the Company’s website for several days after the live event. Alternatively, investors may dial 800-638-5439 or 1-617-614-3945 and use the passcode 66964895. A replay of the teleconference will be available by dialing 888-286-8010 or 1-617-801-6888, passcode 73270889, approximately two hours after the teleconference concludes. The archive of the teleconference will remain available for 30 days.
About Sucampo Pharmaceuticals
Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic catalysis by 15-PGDH of eicosanoids and docosanoids, was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo’s Chairman and CEO. Dr. Ueno founded Sucampo Pharmaceuticals in 1996 with Sachiko Kuno, Ph.D., founding CEO and currently Executive Advisor, International Business Development, and a member of the Board of Directors. For more information, please visit www.sucampo.com.